medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2000, Number 3

<< Back Next >>

Alerg Asma Inmunol Pediatr 2000; 9 (3)

Kawasaki's disease

Ambriz MMJ, Alvarado n

Language: Spanish
References: 16
Page: 96-99
PDF size: 358.83 Kb.


ABSTRACT

This syndrome is characterized by fever and mucocutaneous affectation and of lymphatic nodules, it has autolimited course and that it effects mainly to the infants. It was described for the first time in 1967 by the Dr. Tomisaku Kawasaki. It is more frequent in Japanese and children with Asian ancestors; their incidence varies in each country and it is more frequent in the masculine sex. Their etiology is ignored, it is considered that it can be due to alterations infectious, genetic and/or immunologic. Six clinical approaches have been determined for their diagnosis: fever, conjuntival injection, oral lesions, changes in extremities, rash, linfadenitis; althrough other alterations can be presented to sistemic level. Other frequently opposing abnormalities are the increment in the speed of globular sedimentation and thrombocytosis. Their treatment consists on antiplatelets (SAA or dipiridamol) and gammaglobulin intravenous; the most excellent complications are the aneurisms of the coronary artery. Their presage is good with mortality of 1%.


REFERENCES

  1. Enfermedad de Kawasaki en México. Bol Med Hosp Infant Mex 1991; 48: 409-416.

  2. Enfermedad de Kawasaki. Bol Med Hosp Infant Mex 1991; 48: 383-4.

  3. Enfermedad de Kawasaki en niños mexicanos. Bol Med Hosp Infant Mex 1991; 48: 398-408.

  4. Kawasaki's Disease Epidemiology, Late Prognosis and Therapy. Rheum Dis Clin of North Am 1994; 17: 907-918.

  5. Kawasaki's syndrome. Pediatrics in Review 1996; 17: 153-62.

  6. Kawasaki's Disease. Acta Paedr 1995; 84: 713-5.

  7. Rich R. Clinical and immunology principles and practice. Mosby 1996.

  8. Kawasaki's Disease: Cardiac Sequelae and Management. Pediatr Ann 1997; 26: 112-5.

  9. The Etiology and pathogenesis of Kawasaki's disease-how are we to an answer? Curr Op Infect Dis 1997; 10: 226-232.

  10. Passive surveillance for Kawasaki's disease in San Diego Country. Pediatrics Infect Dis J 1997; 16: 1015-8.

  11. Feigin RC. Textbook of pediatrics infectious disease. J. Saunders 1998.

  12. Intravenous gamma-globulin treatment and retreatment in Kawasaki's diseases. Pediatrics Infect Dis J 1998; 17: 144-8.

  13. Kawasaki's Syndrome. Clin Infec Dis 1999; 28: 167-87.

  14. Changes in epidemic patterns of Kawasaki's disease in Japan. Pediatr Infect Dis J 1999; 18: 64-6.

  15. Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki's Disease. Pediatr 1999; 102: 1469-71.

  16. Cardiac sequelae in recurrent cases of Kawasaki's Disease comparison between the initial of the diseases and recurrent in the same patients. Pediatr 1999; 102: 1469-71.




2020     |     www.medigraphic.com